The purpose of this study is to assess the immunogenicity and safety of the Infanrix hexa booster dose given at 12-18 months of age to infants who received primary vaccination at 6-12 weeks. All infants in this booster study were born to pregnant women who participated in the study 116945 [DTPA (BOOSTRIX)-047]. Register Today!
Anemia in Renal Failure (AKB-6548-CI-0017)
When kidneys are diseased or damaged, they do not make enough EPO, a hormone produced by the kidney which aids in the production and formation of red blood cells in bone marrow. The bone marrow then makes fewer red blood cells, causing anemia. AKB-6548-CI-0017 is a multicenter, randomized, open-label, active-controlled Phase 3 study for the…
Boostrix Vaccine 2 Month (201330)
The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals’ Infanrix hexa, given in the primary vaccination schedule to infants born to pregnant women who participated in study 116945 [DTPA (BOOSTRIX)-047]. This study will help us evaluate if the presence of transplacentally transferred maternal antibodies interfere with the immune response…
Ulcerative Colitis (M14-533)
M14-533 is an extension study of M14-234. The purpose of this study is to evaluate the long-term safety and efficacy of ABT-494 in subjects with Ulcerative Colitis (UC) who have not responded at the end of the induction period in Study M14-234, who have been inadequate responders during the maintenance period of Study M14-234, or…
COPD (PT009002 “Pearl”)
People with COPD usually have one or more of these symptoms: a cough that lasts a long time (longer than 3 months) a cough with mucus feeling short of breath lung infections (the flu, acute bronchitis, pneumonia, etc) that may last longer than other people you know wheezing (a whistling sound when you breathe) feeling…
Ulcerative Colitis (M14-234)
The purpose of the study is to evaluate the safety and efficacy of ABT-494 for induction and maintenance therapy in subjects with moderately to severely active ulcerative colitis. Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining…
Overactive Bladder (178-MA-1005)
Overactive Bladder (OAB) is a frequent condition affecting older adults and the urinary frequency and urgency associated with the condition are often highly debilitating. In addition, OAB related urinary incontinence has been associated with other health related problems in seniors including falls, fractures, urinary tract infections (UTIs), skin infections, depression, and chronic constipation. The purpose…
COPD (PT010005 “Pearl”)
People with COPD usually have one or more of these symptoms: a cough that lasts a long time (longer than 3 months) a cough with mucus feeling short of breath lung infections (the flu, acute bronchitis, pneumonia, etc) that may last longer than other people you know wheezing (a whistling sound when you breathe) feeling…
Uterine Fibroids (M12-817)
The purpose of this study is to determine the safety of elagolix and how elagolix works when compared to placebo in reducing heavy menstrual bleeding, the major symptom of uterine fibroids. Register Today!
Boostrix Vaccine (Pregnant Women)
GSK Biologicals’ reduced-antigen-content dTpa vaccine, Boostrix, is a combination booster vaccine (a vaccine against more than one disease combined into one shot) indicated for individuals from the age of four years onwards against diphtheria, tetanus and pertussis diseases. It was first licensed for use in Germany in 1999. A number of studies have shown that…